Please note: this year, FLORetina-ICOOR 2025 will be held jointly with the 5th World Retinopathy of Prematurity (ROP) Congress.
December 04 - December 07, 2025
Florence, Fortezza da Basso
For info: secretariat@floretina.com
Floretina.com offers a number of live webinars on different topics throughout the year. They are
traditionally planned on Tuesday, at 6.30pm CET/CEST, but if that does not fit with your time
zone, you can always watch the webcast at any time, as we record all sessions and upload them in
the Webinars Archive.
Next events
Past events
Past
surgeries
The incidence in the world of nearsightedness is on the rise. The association with other ocular diseases and the impact of myopia complications are quite frequent. Discover our new section with lessons on medical and surgical topics, webinars on new treatment opportunities.
Faculty: Dominique Brémond-Gignac, Luca Buzzonetti, Paolo Nucci, Arne Ohlendorf, Isabella Puddu, Giuliano Stramare
Surf the presentations on myopia associated diseases held during FLORetina-ICOOR 2024.
Watch now
Surf the presentations on myopia associated diseases held during FLORetina-ICOOR 2023.
Watch now
The editorial team* at Floretina.com is committed to select the news of the month. We
will interview established physicians, as well as young ophthalmologists, scientific advisors
and Industry representatives. Register on the website to receive news notifications!
*Timothy Norris has been working for ten years in medical communication in
the field of ophthalmology. He regularly collaborates as journalist, medical writer and
copywriter with influential newspapers and specialised agencies, including Ocular
Surgery News, Eyeworld, Retina Today and Media Mice. He is currently working for the
media agency Etcetera Communication.
Alcon, the global leader in eye care, will showcase its latest innovation for cataract and vitreoretinal surgery at the FLORetina-ICOOR 2025 Congress in Florence, Italy, December 4-7. Floretina delegates are invited to attend live surgery sessions and visit the Alcon booth to find out more about UNITY® VCS, a versatile platform that offers two configurations: the combined Vitreoretinal Cataract System (VCS) and the standalone Cataract System (CS). Read more
The New England Journal of Medicine (NEJM) recently published a peer-reviewed original paper with the results of a landmark clinical trial demonstrating the efficacy of Science Corporation’s PRIMA brain-computer interface (BCI) retinal implant. The paper showed that PRIMA restored functional central vision to patients suffering from geographic atrophy (GA) due to age-related macular degeneration (AMD), a leading cause of blindness affecting more than 5 million people worldwide. Read more
Diabetic retinopathy (DR) is the leading cause of blindness in working-aged people worldwide[1]. Diabetic macular edema (DME) occurs in nearly 12% of patients with DR and represents a frequent complication of diabetes resulting from disruption of blood-retinal barrier and accumulation of fluid in the retina, which can lead to significant central visual loss if left untreated[2]. Read more
This section features the video recordings of
We welcome professionals, researchers, industry contributors who are registered on Floretina.com to upload and share their diagrams and figures illustrating retinal anatomy or clinical techniques, case series, and ultrasound images. Please read our terms of use and upload your picture.
View the image banks Send your image banksRickettsial infections are caused by a variety of obligate intracellular, Gram-negative bacteria. Ocular involvement is common but often asymptomatic. All ocular structures can be involved, but posterior segment involvement is more common and most severe. Common posterior segment manifestations are inner retinitis with associated vasculitis and mild vitritis. There are various speculations regarding the pathogenesis of rickettsial retinitis. The cotton wool spot-like retinal lesions could result from intraretinal multiplication of organisms or alternatively due to immune complex deposition along retinal vessels.
VIEW IMAGE BANKA case of 48 y/o lady who presented with DOV in RE (6/60) since 15 days. She had a h/o Ca right breast treated with mastectomy 13 years back & was prescribed letrozole(AROMATASE INHIBITOR) 2.5mg OD as she had tested ER +ve. Anterior segment showed cells in AC & anterior vitreous face. Posterior segment revealed disc & macular edema. OCT also showed disc edema & CME. LE examination was WNL. Systemic investigations were WNL. She was asked to stop letrozole after oncology consultation & was prescribed topical prednisolone & nepafenac. Discontinuation of letrozole improved visual acuity to 6/18 within 1 month.
VIEW IMAGE BANKPatient presented with dimunition of vision in right eye,on evaluation patient had re- vitreous haemorrhage,on imaging iofb noted. Planned ppv and metallic iofb removed with the help of maxgrip forceps, through port widening,procedure uneventfull
VIEW IMAGE BANK
A 55-year-old male patient was referred to our medical retina unit for bilateral vision loss occurred in the last year. Fundus examination revealed bilateral macular atrophy with foveal sparing surrounded by yellowish ‘fish tail flecks’ all over the posterior pole. SD-OCT, FAF, FA and ERG were performed. Genetic evaluation confirmed diagnosis of Stargardt Disease.
Read more